Effects of itraconazole and cyclosporine on the pharmacokinetics of sparsentan in healthy male volunteers.

Trial Profile

Effects of itraconazole and cyclosporine on the pharmacokinetics of sparsentan in healthy male volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Sparsentan (Primary) ; Itraconazole
  • Indications Focal segmental glomerulosclerosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Sep 2017 Results assessing potential effects of itraconazole and cyclosporine on sparsentan pharmacokinetics in healthy male volunteers, were published in the Clinical Pharmacology in Drug Development Conference: 2017 Annual Meeting of the American College of Clinical Pharmacology, ACCP 2017.
    • 01 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top